On November 19, 2021, The Pearl River Fisheries Research Institute (PRFRI), Chinese Academy of Fishery Science (CAFS) and shuotang biopharmaceutical Co., Ltd. signed a cooperation agreement on the project of inactivated vaccine of Siniperca chuatsi infectious spleen kidney necrosis virus and rhabdovirus. The two sides work together to give full play to their respective resources in industry related technology, platform, capital and marketing, jointly carry out the R & D, registration and industrialization of the vaccine through complementary advantages, strive to obtain a new veterinary drug certificate as soon as possible, and help the green development of mandarin fish breeding industry in China.
The vaccine was developed by the characteristic fish virus vaccine creation and a regional control innovation team of the Pearl River Institute. Focusing on the inactivated vaccine of Siniperca chuatsi infectious spleen and kidney necrosis virus and rhabdovirus, the team has made a series of innovative achievements in disease epidemiology, vaccine strain screening, cell line construction, vaccine development, quality control, etc, The preclinical research of the vaccine has been completed. In order to promote the registration and industrialization of the vaccine, PRFRI and shuotang biopharmaceutical Co., Ltd. have conducted in-depth communication, exchange and Discussion on jointly carrying out the R & D, registration and industrialization of the vaccine for many times in recent years, and both parties have reached an agreement on the follow-up development plan and intellectual property transfer.
Shuo Teng is a global animal protection company, committed to continuous innovation and development of animal health and sustainable development solutions. With more than 65 years of experience, Shuo Teng provides customers with high-quality drugs, vaccines and diagnostic products, supplemented by genetic testing, biological instruments and a series of professional support. To provide health services for aquaculture, Acquired famak successively (pharmaq) and fishvet group. Shuotang biopharmaceutical Co., Ltd. is located in Suzhou Industrial Park, covering an area of 90000 square meters. It has an animal vaccine R & D center integrating pigs, birds, cattle, pets and aquatic products, a production line with new GMP certification and a first-class animal feeding facility such as circulating aquaculture system. The company has laid out China's aquatic business and strategy since 2017, Integrate global resources and strive to provide Chinese aquaculture customers with solutions for disease diagnosis, prevention and treatment.
The strong alliance between PRFRI and shuotang company will effectively promote the industrialization of aquatic vaccine in China and help the green and healthy development of aquaculture in China.
